| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Units of Endocrinology (A.S., C.B., C.F.) and Genetics (V.G., L.A.M., L.D.), Hospital Casa Sollievo della Sofferenza, Istituto di Ricovero e Cura a Carattere Scientifico, 71013 San Giovanni Rotondo (FG), Italy; Institute of Clinical Science, University Umberto I (S.D.G., S.M.), Rome 00185, Italy; Institute of Internal Medicine, University of Verona (F.B.), Verona 37134, Italy; Departments of Medicine, Physiology, and Human Genetics, McGill University (G.N.H.), Montréal, Canada H3A 2T5; and Departments of Laboratory Medicine and Pathobiology, Medicine, and Genetics, University of Toronto (D.E.C.C.), Toronto, Canada M5S 3G3
Address all correspondence and requests for reprints to: Dr. Alfredo Scillitani, Unit of Endocrinology, Casa Sollievo della Sofferenza Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, viale dei Cappuccini, 71013 San Giovanni Rotondo (FG), Italy. E-mail: alscill{at}tin.it.
Blood ionized calcium (iCa) is a quantitative trait subject to genetic influence. iCa is maintained in a narrow range through the action of the calcium-sensing receptor (CASR) controlling PTH secretion and calcium excretion. A CASR single nucleotide polymorphism (SNP) prevalent in Caucasian populations (A986S) has shown significant association with iCa in a cohort of young women, but association with the neighboring SNPs, R990G and Q1011E, has not been examined. We studied 377 unrelated adults (184 men and 193 women) recruited as healthy adults from a blood donor clinic. The subjects were not taking any medications, nor did they have disorders of calcium metabolism. Relative frequencies for the CASR 986S, 990G, and 1011E minor alleles were 24%, 4%, and 3% respectively. At the A986S locus, subjects with the AA genotype had significantly lower iCa (P = 0.0001) than subjects with one or two S alleles (mean ± SE, 1.221 ± 0.003 vs. 1.239 ± 0.003 mmol/liter). For the R990G site, subjects with the RR genotype had higher iCa than those with one copy of the 990G allele (1.230 ± 0.002 vs. 1.213 ± 0.007 mmol/liter; P = 0.032). With respect to the 1011 locus, iCa was lower in QQ genotype subjects than in the QE group (1.227 ± 0.002 vs. 1.255 ± 0.008 mmol/liter; P = 0.002). After resolution of phase for the doubly heterozygous subjects, analysis was conducted on haplotypes across all three loci. As expected, subjects with SRQ and ARE haplotypes are relatively hypercalcemic, and those with AGQ are hypocalcemic, relative to subjects with the common ARQ haplotype. Multiple regression analysis with clinical covariates (age, sex and menopausal status, creatinine, and PTH) showed that 16.5% of the total variance in iCa may be explained, and the seven CASR haplotypes contribute significantly (P < 0.0001) and substantially (49.1% of the explained variance) to the model, with the following corrected iCa means: ARQ/AGQ, 1.21 ± 0.01; ARQ/ARQ, 1.22 ± 0.01; ARQ/SRQ, 1.24 ± 0.01; SRQ/AGQ, 1.24 ± 0.03; SRQ/SRQ, 1.25 ± 0.01; ARQ/ARE, 1.25 ± 0.01; and SRQ/ARE, 1.27 ± 0.01. Our data confirm the association between iCa and the A986S locus and suggest that R990G and Q1011E are also predictive. Given the significant between-population variations in frequency of variant alleles in this CASR SNP cluster, tri-locus haplotyping may prove to be more informative in studies of association between variation in CASR and disease.
This article has been cited by other articles:
 |
|
 |
|
  D. E C Cole, F. H J Yun, B. Y L Wong, A. Y Shuen, R. A Booth, A. Scillitani, S. Pidasheva, X. Zhou, L. Canaff, and G. N Hendy Calcium-sensing receptor mutations and denaturing high performance liquid chromatography J. Mol. Endocrinol., April 1, 2009; 42(4): 331 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rus, C. Haag, C. Bumke-Vogt, V. Bahr, B. Mayr, M. Mohlig, E. Schulze, K. Frank-Raue, F. Raue, and C. Schofl Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4797 - 4803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Nissen, S. E. Christensen, L. Heickendorff, K. Brixen, and L. Mosekilde Molecular Genetic Analysis of the Calcium Sensing Receptor Gene in Patients Clinically Suspected to Have Familial Hypocalciuric Hypercalcemia: Phenotypic Variation and Mutation Spectrum in a Danish Population J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4373 - 4379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Scillitani, V. Guarnieri, C. Battista, S. De Geronimo, L. A. Muscarella, I. Chiodini, M. Cignarelli, S. Minisola, F. Bertoldo, C. M. Francucci, et al. Primary Hyperparathyroidism and the Presence of Kidney Stones Are Associated with Different Haplotypes of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Corbetta, C Eller-Vainicher, M Filopanti, P Saeli, G Vezzoli, T Arcidiacono, P Loli, M L Syren, L Soldati, P Beck-Peccoz, et al. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism. Eur. J. Endocrinol., November 1, 2006; 155(5): 687 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wystrychowski, S. Pidasheva, L. Canaff, J. Chudek, F. Kokot, A. Wiecek, and G. N. Hendy Functional Characterization of Calcium-Sensing Receptor Codon 227 Mutations Presenting as Either Familial (Benign) Hypocalciuric Hypercalcemia or Neonatal Hyperparathyroidism J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 864 - 870. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
